Laxminarayan Bhat
President, Chief Executive Officer, Director
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $450,000 | $607,500 |
| 2023 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $450,000 | $2,764,747 |
| 2022 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $400,000 | $560,000 |
| 2021 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $400,000 | $600,054 |
| 2020 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $247,952 | $247,952 |
| 2019 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $240,000 | $240,000 |
Earnings-call appearances
-
Lytham Partners Spring 2026 Investor Conference2026-05-28
Reviva Pharmaceuticals Holdings, Inc. (RVPH)